Analyst Conference Summaries

Biotechnology Investor Aids

Tetraphase Pharmaceuticals

press release date: August 2, 2018 (press release only)

Achaogen: Buy Before The June 25 PDUFA Date [May 24, 2018 at Seeking Alpha]

Tetraphase Pharmaceuticals, My Favorite 2H 2018 Biotech [May 23, 2018 at Seeking Alpha]

Tetraphase Pharmaceuticals Trial Failure May Mask Value [February 27, 2018 at Seeking Alpha]

May 3, 2018
August 2, 2018

Tetraphase Pharmaceuticals (TTPH) is a clinical-stage biotechnology company specializing in multidrug-resistant antibiotic therapies.

Tetraphase Pharmaceutical web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2017 William P. Meyers